<img alt="" src="https://secure.heat6have.com/192007.png" style="display:none;">
Gold-hospice-news-product-of-the-year-light

BetterRX Guardrails™ Wins 2026 Hospice News Product of the Year Learn More

5 min read

Hospice Operational Efficiency Benchmarks Every COO Should Track

Hospice Operational Efficiency Benchmarks Every COO Should Track
THE SHORT ANSWER

Hospice operational efficiency benchmarks are the measurable standards hospice leaders use to compare how efficiently medications, staffing, and delivery costs are performing against what's realistically achievable, rather than just against last quarter. BetterRX gives COOs real-time reporting, including delivery spend benchmarks, instead of leaving them to piece together a picture from month-old reports.

Why Most Hospices Benchmark Against the Wrong Thing

Hospice operational efficiency benchmarks are standards for comparing performance across staffing, medication delivery, and cost against what's realistically achievable, not just against the organization's own history. That distinction matters because comparing this quarter to last quarter only tells a COO whether things got better or worse. It says nothing about whether "better" is actually good.

Many hospices default to internal trend lines because they're the easiest data to get. A retrospective PBM report might show delivery fees trending down month over month, which looks like progress. It doesn't say whether those fees are still twice what a well-run operation should expect, because there's no external or structural benchmark in the comparison at all.

 

Four Benchmark Categories Worth Tracking

A useful set of operational efficiency benchmarks doesn't need to be complicated. Four categories cover most of what a COO actually needs to know.

1. Nurse time per medication order, measured from decision to fulfillment, not just from order placement to pharmacy confirmation.

2. Delivery cost per patient, including how much of that cost comes from avoidable STAT and after-hours fees versus genuinely urgent need.

3. Medication service failure rate, meaning how often an order is delayed, wrong, or has to be re-processed.

4. Time to visibility, meaning how long it takes leadership to see a cost or utilization problem after it happens, not after the billing cycle closes.

 

How to Tell If a Benchmark Is Actually Worth Tracking

Not every number that looks like a benchmark deserves a place on a COO's dashboard. Before adding one, it helps to ask a few questions about where it comes from and how it will actually be used.

1. Does this number compare against a realistic standard, or only against the organization's own past performance? A number with no external reference point can't tell you whether you're actually doing well.

2. How fresh is the data behind it? A benchmark refreshed monthly can confirm a trend, but it can't help anyone act while the underlying problem is still small and cheap to fix.

3. Will anyone actually change a decision because of this number? A benchmark nobody acts on is a statistic, not a management tool, no matter how accurate it is.

A short list of benchmarks that pass all three tests is worth more to a COO than a long dashboard full of numbers that don't.

 

The Problem With Retrospective Benchmarking

The traditional PBM model typically reports these categories after the fact, often weeks after the activity they describe. A benchmark that arrives a month late can confirm a problem existed. It can't help a COO act on it while it's still cheap to fix.

That lag also makes benchmarking feel like an academic exercise rather than an operational tool. If a delivery cost benchmark only updates once a month, it functions more like a report card than a dashboard, and report cards don't change behavior in the moment a cost is actually being incurred.

There's a compounding effect to consider as well. A benchmark gap that goes unnoticed for a month at one location doesn't just cost that location a month of avoidable spend. If the same gap exists at every site because nobody caught it structurally, the delay multiplies across the whole organization every reporting cycle it goes unaddressed. That's the real cost of retrospective benchmarking: not just the lag itself, but how much larger the eventual fix has to be by the time anyone notices.

 

The BetterRX Model: Benchmarks Leadership Can Act On

Intelligent Medication Management, part of The Better Way to Manage Hospice Medications, gives COOs a PPD Performance Dashboard and more than thirty reports across cost analysis, clinical utilization, formulary compliance, and fill volume, with live reporting rather than waiting for a billing cycle to close. That's what turns a benchmark from a historical fact into an operating tool.

BetterRX's Delivery Report is a direct example of benchmarking done at the point where it can still change a decision. In Beta testing, 86% of participants agreed the metrics were easy to understand, 90% agreed the benchmarks identified opportunities, and 90% agreed the report provided new visibility into delivery spend, according to BetterRX's Delivery Report Beta Survey. That's a feature built specifically to answer the question COOs are usually asking: is this delivery cost normal, or is it a problem worth fixing?

"BetterRX and the support team truly do save our nurses time in the field, save time on medication orders and reduce any pharmacy delays to our patients. The platform is easy to use and dedicated to helping the company save in all areas."

- VOC respondent

At the company level, clients have given BetterRX an "A" rating in BetterRX's Voice of the Customer survey across six consecutive years, and 99% of clients consider BetterRX a trusted partner, with 91% saying "definitely yes" and 8% saying "probably yes," per BetterRX's 2026 Voice of the Customer survey. Those results reflect what hospices experience when real-time visibility and responsive support are built into how medication management runs every day.

 

Turning Benchmarks Into Proactive Cost Control

Benchmarks only earn their place on a COO's dashboard if they change a decision. Real-time visibility into nurse time, delivery cost, and service failures gives leadership the ability to intervene while a problem is still small, rather than explaining it in a quarterly review after it has already compounded across every location.

That's the practical difference between measuring operational efficiency and improving it. A benchmark that only confirms what already happened is not a reflection of proactive cost control. A benchmark a COO can act on the same week it appears is the one that actually protects margin and nurse time.

It's also worth being honest about what a benchmark can't do. No dashboard replaces clinical judgment, and no report should ever be the reason a nurse hesitates on an urgent order. The value of real-time benchmarking is that it handles the routine visibility work automatically, so leadership's attention goes to the exceptions that genuinely need it instead of being spread thin across every routine number on the page.

 

Frequently Asked Questions

  • Measurable standards for comparing nurse time, delivery cost, and service failure rates against what's realistically achievable, not just against the organization's own past performance.

  • It shows whether performance improved, but it doesn't say whether the current level is actually good compared to what a well-run operation should expect.

  • Nurse time per medication order, delivery cost per patient, medication service failure rate, and how quickly leadership sees a problem after it happens.

  • Reports that arrive weeks after the activity they describe can only confirm a problem happened. They can't help leadership act while it's still cheap to fix.

  • Through a PPD Performance Dashboard and reports like the Delivery Report. In pre-launch testing, 90% of participants agreed the Delivery Report provides new visibility into delivery spend (Source: 2026 BetterRX Delivery Report Beta Survey).

  • Clients have given BetterRX an "A" rating in BetterRX's Voice of the Customer survey across six consecutive years, and 99% of clients consider BetterRX a trusted partner, per BetterRX's 2026 Voice of the Customer survey.

  • Check whether it compares against a realistic standard rather than just past performance, how current the underlying data is, and whether anyone would actually change a decision based on it.

NEXT STEP

See how BetterRX turns real-time reporting into benchmarks hospice COOs can actually act on.

Schedule a Call